When compared with the frequency of occurrence in the general population, herpes zoster patients were not at increased risk for cancer.More

Designed to stimulate T cell and B cell immune responses, GEN-003 is an investigational vaccine that works to potentially reduce the frequency and severity of Herpes Simplex Virus type 2 (HSV-2) infection. More